DoriVac, a finalist in the Student Health & Life Sciences Track, treats cancer by harnessing DNA nanotechnology to deliver highly cancer-patient-specific antigens and control the spatial geometry of co-presented immunostimulatory ligands with nano-scale precision.

Learn more about DoriVac: https://pic2023.innovationlabs.harvar...

The yearly President’s Innovation Challenge is an invitation to Harvard students and select alumni & affiliate-led ventures to propel their ideas forward. The PIC is also an opportunity to win a share of $515,000 in non-dilutive funding, made possible by a gift from the Bertarelli Foundation. Throughout the seven-month process, teams develop their ventures with robust support from the Harvard Innovation Labs.

https://innovationlabs.harvard.edu/